Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes

Author： Shi Lizheng Juarez Rodrigo Hackworth Jodi Edgell Eric T. Haro Josep Maria Vieta Eduard Tohen Mauricio F.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.5, 2006-05, pp. : 961-966

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4‐week, open‐label clinical study

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 10, 2015-10 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Open-Label Pilot Study of Homeopathic Treatment of Attention Deficit Hyperactivity Disorder in Children and Youth

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 21, Iss. 5, 2014-09 ,pp. : 302-309

Karger

Access to resources Recommend Favorite

Remission of Generalized Anxiety Disorder after 6 Months of Open-Label Treatment with Venlafaxine XR

Psychotherapy and Psychosomatics, Vol. 82, Iss. 6, 2013-09 ,pp. : 363-371

Karger

Access to resources Recommend Favorite

A Multicenter, Open-Label Clinical Study of Micafungin (FK463) in the Treatment of Deep-seated Mycosis in Japan

By Kohno Shigeru Masaoka Toru Yamaguchi Hideyo Mori Takeshi Urabe Akio Ito Akira Niki Yoshihito Ikemoto Hideo

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 5, 2004-05 ,pp. : 372-379

Informa Healthcare

Access to resources Recommend Favorite

A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 2016-2024

John Wiley & Sons Inc

Access to resources Recommend Favorite